Patient-reported outcomes in Hodgkin lymphoma trials: a systematic review
DiscussionsOnly one-third of RCTs in HL report PROs as an outcome and only half present the outcome in subsequent publications, showcasing the underreporting of PROs in trials. Disease-specific PROMs are underutilized in the assessment of QoL in HL patients. Guidance on the assessment of PROs is needed to inform on comprehensive outcomes important to patients.Systematic review registrationhttps://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=391552, identifier CRD42023391552.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
More News: Brain | Cancer & Oncology | Clinical Trials | Hodgkin's Disease | Infertility | Lymphoma | Men | Neurology | Reproduction Medicine | Study | Toxicology